alanine aminotransferase (ALT) , and alkaline phosphatase (ALP) were also reduced via cotreatment with MWEs compared with CCl4 treatment alone. Cotreatment with MWE evidently reducer CCl4 -induced liver weight and inhibited lipid deposition and fibrogenesis. In a similar manner. cotreatment with silymarin, a well-known liver protective agent, also reversed the CCl4-induced effects, such as redued TBARS formation, decreased serum AST,ALT, and ALP level, blocked lipid accumulation ,and liver fibrosis. Furthermore, MWEs attenuated the proinflammatory genes such as cyclooxygenase 2, nuclear factor kappa B, and inducible nitric oxide synthase expression. The current findings suggest that MWes such as silymarin exhibit protective and curative effects against CCl4-induced liver damage and fibrosis via decreased lipid peroxidation and inhibited proinflammatory gene expression.